DNAL1 antibody (C-Term)
Quick Overview for DNAL1 antibody (C-Term) (ABIN499752)
Target
See all DNAL1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- This antibody reacts top DNAL1.
-
Purification
- Affinity chromatography purified via peptide column
-
Immunogen
- DNAL1 antibody was raised against a 17 amino acid peptide from near the carboxy terminus of human DNAL1.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
ELISA. Western Blot: 1 - 2 μg/mL. Immunocytochemistry.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS containing 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Store the antibody undiluted at 2-8 °C.
-
-
- DNAL1 (Dynein, Axonemal, Light Chain 1 (DNAL1))
-
Alternative Name
- DNAL1
-
Background
- DNAL1 was identified as a potential candidate gene for primary ciliary dyskinesia (PCD), a genetically heterologous disorder characterized by chronic infections of the upper and lower airways that often leads to permanent lung damage, randomization of left/right body symmetry, and reduced fertility. DNAL1 is reported to be expressed solely in tissues carrying motile cilia for flagella and interacts with DNAH5, a protein that when mutated has been shown to result in PCD. It has been suggested that DNAL1 serves a regulatory function for DNAH5 activity in outer dynein arms of sperm flagella, respiratory cilia, and ependymal cilia. DNAL1 has also been recently identified as an HIV dependency factor (HDF), suggesting that DNAL1 may be an important drug target in HIV treatment. At least two isoforms of DNAL1 are known to exist.Synonyms: C14orf168, Dynein light chain 1 axonemal
-
Gene ID
- 83544
-
NCBI Accession
- NP_113615
-
UniProt
- Q4LDG9
Target
-